iCycleBeads: New iPhone application for planning and avoiding pregnancy

December 02, 2010

WASHINGTON, D.C. - A scientifically-based family planning tool developed by researchers from Georgetown University's Institute for Reproductive Health, a part of Georgetown University Medical Center (GUMC), is now available as an easy-to-use iPhone ®, iPod touch® or iPad™ application. iCycleBeads™ is the first software application that enables a woman to plan or avoid pregnancy easily and effectively, entirely through the information provided by the application.

To use iCycleBeads a woman simply enters into the "app" the starting date of her most recent period and any historical data on her menstrual cycles that she may have. At the touch of a button, iCycleBeads shows her where she is in her cycle and whether she is on a day when pregnancy is likely or not.

The "app" is designed as a virtual representation of actual CycleBeads®, a string of 32 color-coded beads. A calendar view is also available. A red bead or box marks the first day of a woman's cycle, brown represents days when pregnancy is unlikely, and white represents days when pregnancy is likely. The user will also receive alerts that notify her when she is in her fertile window, when she is on a day when pregnancy is unlikely, and when she is likely to get her period. An alert will also prompt her to enter her cycle data if she forgets.

"Electronic devices like iPhones are increasingly popular and we see this technology as an important new way to reach women. We think that iCycleBeads will appeal to any woman who is interested in effectively and easily managing her fertility and uses a compatible mobile digital device," said Victoria Jennings, Ph.D., director of the Institute for Reproductive Health and professor of obstetrics and gynecology at GUMC.

The new "app" is modeled on the popular family planning tool, CycleBeads. Based on sophisticated computer modeling of reproductive physiology data and tested in large-clinical trials, CycleBeads lets a woman know her cycle length and clearly identifies days eight through 19 of her cycle as the days during which she is fertile. These 12 days take into account the life span of the woman's egg (about 24 hours) and the viable life of sperm (about five days) as well as the variation in the actual timing of ovulation from one cycle to the next.

The Institute for Reproductive Health has developed the only natural methods of family planning that have been clinically tested and introduced on an international scale. CycleBeads and iCycleBeads were designed for women with cycles between 26 and 32 days, an estimated 80 percent of women of reproductive age.

Cycle Technologies, the manufacturer of CycleBeads, is offering iCycleBeads at the iPhone Apple store. "We are pleased that Cycle Technologies has taken this fertility management tool high tech. While many women still prefer having something tangible like CycleBeads to hold in their hands, having an electronic version will make this family planning method available to the millions of women who use computerized "apps" for so many things every day," said Jennings, an internationally respected family planning researcher who is a co-developer of CycleBeads.

iCycleBeads will be available worldwide. Potential users of this new "app" include many of the approximately 60 million women in the United States who are of reproductive age - 15 to 44 years of age. In the U.S. alone, there are more than 3 million unplanned pregnancies each year. An estimated twenty percent of women who believe they are infertile are actually mistiming their efforts to get pregnant. iCycleBeads can help address these issues with a high tech solution.
-end-
Information on the Institute for Reproductive Health can be found at www.irh.org. High resolution screen shots of the iCycleBeads "app" are available upon request.

CycleBeads is a patented technology owned by Georgetown University that has been licensed to Cycle Technologies for commercialization. CycleBeads and iCycleBeads are both protected under this patent. Jennings is one of the inventors on the patent. All royalties support Institute for Reproductive Health programs in developing countries.

About the Institute for Reproductive Health

The Institute is dedicated to helping women and men make informed choices about family planning and providing them with simple and effective natural options. As part of Georgetown University's Department of Obstetrics and Gynecology, the Institute conducts research to develop natural methods of family
 planning and tests them in service delivery settings.

About Georgetown University Medical Center

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through Georgetown's affiliation with MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Georgetown Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO). In fiscal year 2009-2010, GUMC accounted for 79 percent of Georgetown University's extramural research funding.

Georgetown University Medical Center

Related Fertility Articles from Brightsurf:

What are your chances of having a second IVF baby after fertility treatment for the first?
As the restrictions on fertility clinics start to be lifted and IVF treatment resumes, research published in Human Reproduction journal offers reassuring news to women who have had to delay their treatment for a second IVF baby because of the coronavirus.

Fertility preservation use among transgender adolescents
Transgender adolescents often seek hormonal intervention to achieve a body consistent with their gender identity and those interventions affect reproductive function.

A new way to assess male fertility
Current tests for male fertility include measuring the concentration and motility of spermatozoa.

Male fertility after chemotherapy: New questions raised
Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

Vaping may harm fertility in young women
E-cigarette usage may impair fertility and pregnancy outcomes, according to a mouse study published in the Journal of the Endocrine Society.

Are fertility apps useful?
Researchers at EPFL and Stanford have carried out an analysis of the largest datasets from fertility awareness apps.

Marijuana and fertility: Five things to know
For patients who smoke marijuana and their physicians, 'Five things to know about ... marijuana and fertility' provides useful information for people who may want to conceive.

How could a changing climate affect human fertility?
Human adaptation to climate change may include changes in fertility, according to a new study by an international group of researchers.

Migrants face a trade-off between status and fertility
Researchers from the universities of Helsinki, Turku and Missouri as well as the Family Federation of Finland present the first results from a new, extraordinarily comprehensive population-wide dataset that details the lives of over 160,000 World War II evacuees in terms of integration.

Phthalates may impair fertility in female mice
A phthalate found in many plastic and personal care products may decrease fertility in female mice, a new study found.

Read More: Fertility News and Fertility Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.